| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 1994 Oxford University Press
OTHER |
Analysis of mutations and alternative splicing patterns in the CFTR gene using mRNA derived from nasal epithelial cells
Paediatric Molecular Genetics, Institute of Molecular Medicine, Oxford University, John Radcliffe Hospital Oxford OX3 9DU, UK
*To whom correspondence should be addressed
Received March 22, 1994; Revised April 22, 1994; Accepted April 22, 1994
Ten to fifteen percent of CF chromosomes carry mutations which are not detected by routine screening of the CFTR gene for known mutations. Many techniques have been used to screen the CFTR gene for these remaining mutations. Most of the methods use genomlc DNA, and since the CFTR gene contains 27 exons, are necessarily labour intensive. We have screened the entire coding region of CFTR, by chemical cleavage of 7 overlapping segments of amplified cDNA. Using this method we have identified 4 sequence changes which had not been detected by screening genomlc DNA, and successfully detected 10 out of 13 known mutations. In addition, we have Identified 8 alternatively spliced forms of CFTR mRNA, 4 of which have not been described previously. These include transcripts lacking a) exon 3, b) exons 2 + 3, c) exons 9 + 12, and d) the final 357 bp of exon 15 as a result of use of the cryptic splice donor site CA2863/ GTTCGT).
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Raponi, F. E. Baralle, and F. Pagani Reduced splicing efficiency induced by synonymous substitutions may generate a substrate for natural selection of new splicing isoforms: the case of CFTR exon 12 Nucleic Acids Res., January 28, 2007; 35(2): 606 - 613. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Dayangac, H. Erdem, E. Yilmaz, A. Sahin, C. Sohn, M. Ozguc, and T. Dork Mutations of the CFTR gene in Turkish patients with congenital bilateral absence of the vas deferens Hum. Reprod., May 1, 2004; 19(5): 1094 - 1100. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Aznarez, E. M. Chan, J. Zielenski, B. J. Blencowe, and L.-C. Tsui Characterization of disease-associated mutations affecting an exonic splicing enhancer and two cryptic splice sites in exon 13 of the cystic fibrosis transmembrane conductance regulator gene Hum. Mol. Genet., August 15, 2003; 12(16): 2031 - 2040. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Pagani, C. Stuani, M. Tzetis, E. Kanavakis, A. Efthymiadou, S. Doudounakis, T. Casals, and F. E. Baralle New type of disease causing mutations: the example of the composite exonic regulatory elements of splicing in CFTR exon 12 Hum. Mol. Genet., May 15, 2003; 12(10): 1111 - 1120. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. C. Broackes-Carter, N. Mouchel, D. Gill, S. Hyde, J. Bassett, and A. Harris Temporal regulation of CFTR expression during ovine lung development: implications for CF gene therapy Hum. Mol. Genet., January 1, 2002; 11(2): 125 - 131. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Tarran, M. A. Gray, M. J. Evans, W. H. Colledge, R. Ratcliff, and B. E. Argent Basal chloride currents in murine airway epithelial cells: modulation by CFTR Am J Physiol Cell Physiol, April 1, 1998; 274(4): C904 - C913. [Abstract] [Full Text] [PDF] |
||||



